Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DESIRE is a proprietary, prescription-only Ayurvedic formulation developed by BOHECO (Bombay Hemp Company) to support sexual and reproductive health in both men and women. Formulated in capsule form, the product combines standardized Cannabis (Vijaya) leaf powder with traditional Ayurvedic adaptogens and aphrodisiacs, including Ashwagandha (Withania somnifera), Kaunch Beej (Mucuna pruriens), Shatavari (Asparagus racemosus), and Gokshura (Tribulus terrestris). DESIRE works primarily by modulating the body's endocannabinoid system (ECS) through the binding of cannabinoids to CB1 and CB2 receptors, which helps regulate mood, reduce performance-related anxiety, and support hormonal balance. It is marketed in India under AYUSH regulations for addressing stress-induced intimacy challenges, low libido, and reduced stamina.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on DESIRE.